Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Morning Exposure to Red Light Improves Declining Vision

By HospiMedica International staff writers
Posted on 09 Dec 2021
Weekly exposure to deep red light (650–900 nm wavelength), when delivered in the morning, can enhance color vision in the aged human retina, according to a new study.

Researchers at University College London (UCL; United Kingdom) conducted a study on the effects of deep red light in humans, building on previous findings in mice, bumblebees, and fruit flies that showed significant improvements in the function of the retina's photoreceptors when their eyes were exposed to 670 nm deep red light. More...
For the study, 20 participants (34-70 years of age, 13 female) were exposed to three minutes of deep red light between 8am and 9am. Color vision was tested before and after exposure, and again three hours post exposure. Ten participants were also tested one week post exposure.

The results revealed that on average, there was a significant 17% improvement in participant’s color vision following just a single three minute 670 nm exposure, which lasted for a whole week; in some of the older participants there was a 20% improvement, also lasting a week. However, when the test was conducted a in the afternoon--a few months on from the first test to ensure any positive effects had been 'washed out'--zero improvement was seen. The study was published on November 24, 2021, in Scientific Reports.

“Mitochondria have specific sensitivities to long wavelengths, and morning exposure is absolutely key to achieving improvements in declining vision. A simple LED device once a week recharges the energy system that has declined in the retina cells, rather like re-charging a battery,” said senior author Professor Glen Jeffery, PhD, of the UCL Institute of Ophthalmology. “We demonstrate that one single exposure to long wave deep red light in the morning can significantly improve declining vision, which is a major health and wellbeing issue, affecting millions of people globally.”

In humans around 40 years old, cells in the eye's retina begin to age, partly since the mitochondria, whose role is to produce adenosine triphosphate (ATP, a molecule that carries energy within cells), also age. Since mitochondrial density is greatest in the retina's photoreceptor cells, the retina ages more rapidly than other organs. Deep red light exposure partially restores ATP generation ability by reducing nanoscopic interfacial water viscosity around the ATP rota pumps, thus improving their efficiency.

Related Links:
University College London


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.